Teligent Share Holder Equity 2010-2021 | TLGT
Teligent share holder equity from 2010 to 2021. Share holder equity can be defined as the sum of preferred and common equity items
Teligent Annual Share Holder Equity
(Millions of US $) |
| 2020 |
$-110 |
| 2019 |
$-5 |
| 2018 |
$18 |
| 2017 |
$45 |
| 2016 |
$57 |
| 2015 |
$67 |
| 2014 |
$39 |
| 2013 |
$7 |
| 2012 |
$6 |
| 2011 |
$8 |
| 2010 |
$10 |
| 2009 |
$5 |
Teligent Quarterly Share Holder Equity
(Millions of US $) |
| 2021-06-30 |
$-44 |
| 2021-03-31 |
$-32 |
| 2020-12-31 |
$-110 |
| 2020-09-30 |
$-40 |
| 2020-06-30 |
$-38 |
| 2020-03-31 |
$-32 |
| 2019-12-31 |
$-5 |
| 2019-09-30 |
$-0 |
| 2019-06-30 |
$7 |
| 2019-03-31 |
$10 |
| 2018-12-31 |
$18 |
| 2018-09-30 |
$36 |
| 2018-06-30 |
$39 |
| 2018-03-31 |
$40 |
| 2017-12-31 |
$45 |
| 2017-09-30 |
$51 |
| 2017-06-30 |
$58 |
| 2017-03-31 |
$58 |
| 2016-12-31 |
$57 |
| 2016-09-30 |
$62 |
| 2016-06-30 |
$64 |
| 2016-03-31 |
$67 |
| 2015-12-31 |
$67 |
| 2015-09-30 |
$73 |
| 2015-06-30 |
$75 |
| 2015-03-31 |
$46 |
| 2014-12-31 |
$39 |
| 2014-09-30 |
$33 |
| 2014-06-30 |
$8 |
| 2014-03-31 |
$8 |
| 2013-12-31 |
$7 |
| 2013-09-30 |
$6 |
| 2013-06-30 |
$6 |
| 2013-03-31 |
$6 |
| 2012-12-31 |
$6 |
| 2012-09-30 |
$5 |
| 2012-06-30 |
$7 |
| 2012-03-31 |
$7 |
| 2011-12-31 |
$8 |
| 2011-09-30 |
$8 |
| 2011-06-30 |
$9 |
| 2011-03-31 |
$9 |
| 2010-12-31 |
$10 |
| 2010-09-30 |
$4 |
| 2010-06-30 |
$5 |
| 2010-03-31 |
$6 |
| 2009-12-31 |
$5 |
| 2009-09-30 |
$6 |
| 2009-06-30 |
$7 |
| 2009-03-31 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
